AstraZeneca Purchases US Biologics Manufacturing Facility to Support Growing Pipeline
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- US futures steady as oil retreats ahead of earnings deluge, Fed decision
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Oil slips but stays near six-month highs on Saudi attacks
- EQT to acquire Range Resources in $50 billion all-stock deal
AstraZeneca (AZN) Acquires Biologics Manufacturing Facility from Amgen (AMGN)
September 11, 2015 7:02 AM EDTAstraZeneca (NYSE: AZN) added to its biologics manufacturing capability in the US with the purchase of a high-tech biologics bulk manufacturing facility from Amgen Inc (Nasdaq: AMGN). Over time, the LakeCentre facility, located in Boulder, Colorado will increase manufacturing and production capacity to support the companys extensive portfolio of biologics medicines.
AstraZeneca plans to start staffing the facility immediately to... More



